Scientific Reference
Selank + Semax
Evidence profile: Component evidence only — this formulation has not itself been studied
This combination pairs neurotrophic and neurotransmitter-modulating peptides studied for cognitive and stress-response signalling pathways.\n\nSemax influences neurotrophic activity, while Selank modulates neurotransmitter systems. No clinical trials have evaluated the combination.
Published Research
[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]
Medvedev VE et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014 · Clinical · Evidence for Selank
PMID 25176261 — View on PubMed